Review



plaque-forming units per milliliter  (GraphPad Software Inc)


Bioz Verified Symbol GraphPad Software Inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    GraphPad Software Inc plaque-forming units per milliliter
    Plaque Forming Units Per Milliliter, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plaque-forming+units/pm37807721-295-8-13?v=GraphPad+Software+Inc
    Average 90 stars, based on 1 article reviews
    plaque-forming units per milliliter - by Bioz Stars, 2026-06
    90/100 stars

    Images



    Similar Products

    15597b1 plaque forming unit of 1 57 1011  (ATCC)
    95
    ATCC 15597b1 plaque forming unit of 1 57 1011
    15597b1 Plaque Forming Unit Of 1 57 1011, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plaque-forming+units/10__1016_slash_j__lwt__2022__114172-45-28-27?v=ATCC
    Average 95 stars, based on 1 article reviews
    15597b1 plaque forming unit of 1 57 1011 - by Bioz Stars, 2026-06
    95/100 stars
    		  Buy from Supplier
    plaque forming unit  (Aslan Pharmaceuticals)
    90
    Aslan Pharmaceuticals plaque forming unit
    Plaque Forming Unit, supplied by Aslan Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plaque-forming+units/10__1016_slash_j__mran__2024__100293-106-15-19?v=Aslan+Pharmaceuticals
    Average 90 stars, based on 1 article reviews
    plaque forming unit - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    jx-594 1 × 10 plaque-forming units  (SillaJen Inc)
    90
    SillaJen Inc jx-594 1 × 10 plaque-forming units
    Jx 594 1 × 10 Plaque Forming Units, supplied by SillaJen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plaque-forming+units/pmc10829278-36-1-7?v=SillaJen+Inc
    Average 90 stars, based on 1 article reviews
    jx-594 1 × 10 plaque-forming units - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    plaque-forming units per milliliter  (GraphPad Software Inc)
    90
    GraphPad Software Inc plaque-forming units per milliliter
    Plaque Forming Units Per Milliliter, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plaque-forming+units/pm37807721-295-8-13?v=GraphPad+Software+Inc
    Average 90 stars, based on 1 article reviews
    plaque-forming units per milliliter - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    plaque forming units (pfu)/ml clade ii mpxv ma001  (rocky mountain labs)
    90
    rocky mountain labs plaque forming units (pfu)/ml clade ii mpxv ma001
    Plaque Forming Units (Pfu)/Ml Clade Ii Mpxv Ma001, supplied by rocky mountain labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plaque-forming+units/pm37735747-28-12-21?v=rocky+mountain+labs
    Average 90 stars, based on 1 article reviews
    plaque forming units (pfu)/ml clade ii mpxv ma001 - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    3 × 10 7 plaque-forming units ad5-cmv-gfp  (Vector Biolabs)
    90
    Vector Biolabs 3 × 10 7 plaque-forming units ad5-cmv-gfp
    Wnt3a reduces ocular hypertension in dexamethasone (Dex)–treated mice. A: GTM3 cells were transfected with the glucocorticoid receptor (GR) signaling reporter vector and transduced with the <t>Ad5-CMV-GFP</t> or Ad5-CMV-Wnt3a+mCherry before luciferase assays. Data were analyzed using one-way analysis of variance and Sidak post-hoc tests. B: Three-month–old female C57BL/6J mice received binocular periocular Dex-acetate (Dex-Ac) injection once a week throughout the study (arrow on the left) after baseline intraocular pressure (IOP) establishment. After ocular hypertension development, Ad5-CMV-GFP was injected intravitreally into one eye and Ad5-CMV-Wnt3a+mCherry was injected into the fellow eye (arrow on the right). Mouse IOP was measured under isoflurane anesthesia about once a week throughout the study in a masked manner. Paired t-test was used to compare IOP at each time point. C: Hematoxylin and eosin (H&E) staining of a mouse eye section transduced with Ad5-Wnt3a-mCherry. D: Immunostaining of a section adjacent to C using the anti-mCherry antibody (red; pseudocolor). Data are given as means ± SD of GR signaling activity (A) or means ± SEM of IOP (B). N = 8 (A); N = 17 (B). ∗P < 0.05; ∗∗P < 0.01, and ∗∗∗∗P < 0.0001. Scale bar = 40 μm (C).
    3 × 10 7 Plaque Forming Units Ad5 Cmv Gfp, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plaque-forming+units/pmc08176142-266-17-38?v=Vector+Biolabs
    Average 90 stars, based on 1 article reviews
    3 × 10 7 plaque-forming units ad5-cmv-gfp - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    3 × 10 7 plaque-forming units ad5-cmv-mousewnt3a+mcherry  (Vector Biolabs)
    90
    Vector Biolabs 3 × 10 7 plaque-forming units ad5-cmv-mousewnt3a+mcherry
    Wnt3a reduces ocular hypertension in dexamethasone (Dex)–treated mice. A: GTM3 cells were transfected with the glucocorticoid receptor (GR) signaling reporter vector and transduced with the <t>Ad5-CMV-GFP</t> or Ad5-CMV-Wnt3a+mCherry before luciferase assays. Data were analyzed using one-way analysis of variance and Sidak post-hoc tests. B: Three-month–old female C57BL/6J mice received binocular periocular Dex-acetate (Dex-Ac) injection once a week throughout the study (arrow on the left) after baseline intraocular pressure (IOP) establishment. After ocular hypertension development, Ad5-CMV-GFP was injected intravitreally into one eye and Ad5-CMV-Wnt3a+mCherry was injected into the fellow eye (arrow on the right). Mouse IOP was measured under isoflurane anesthesia about once a week throughout the study in a masked manner. Paired t-test was used to compare IOP at each time point. C: Hematoxylin and eosin (H&E) staining of a mouse eye section transduced with Ad5-Wnt3a-mCherry. D: Immunostaining of a section adjacent to C using the anti-mCherry antibody (red; pseudocolor). Data are given as means ± SD of GR signaling activity (A) or means ± SEM of IOP (B). N = 8 (A); N = 17 (B). ∗P < 0.05; ∗∗P < 0.01, and ∗∗∗∗P < 0.0001. Scale bar = 40 μm (C).
    3 × 10 7 Plaque Forming Units Ad5 Cmv Mousewnt3a+Mcherry, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plaque-forming+units/pmc08176142-266-32-38?v=Vector+Biolabs
    Average 90 stars, based on 1 article reviews
    3 × 10 7 plaque-forming units ad5-cmv-mousewnt3a+mcherry - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    plaque-forming units  (GraphPad Software Inc)
    90
    GraphPad Software Inc plaque-forming units
    Wnt3a reduces ocular hypertension in dexamethasone (Dex)–treated mice. A: GTM3 cells were transfected with the glucocorticoid receptor (GR) signaling reporter vector and transduced with the <t>Ad5-CMV-GFP</t> or Ad5-CMV-Wnt3a+mCherry before luciferase assays. Data were analyzed using one-way analysis of variance and Sidak post-hoc tests. B: Three-month–old female C57BL/6J mice received binocular periocular Dex-acetate (Dex-Ac) injection once a week throughout the study (arrow on the left) after baseline intraocular pressure (IOP) establishment. After ocular hypertension development, Ad5-CMV-GFP was injected intravitreally into one eye and Ad5-CMV-Wnt3a+mCherry was injected into the fellow eye (arrow on the right). Mouse IOP was measured under isoflurane anesthesia about once a week throughout the study in a masked manner. Paired t-test was used to compare IOP at each time point. C: Hematoxylin and eosin (H&E) staining of a mouse eye section transduced with Ad5-Wnt3a-mCherry. D: Immunostaining of a section adjacent to C using the anti-mCherry antibody (red; pseudocolor). Data are given as means ± SD of GR signaling activity (A) or means ± SEM of IOP (B). N = 8 (A); N = 17 (B). ∗P < 0.05; ∗∗P < 0.01, and ∗∗∗∗P < 0.0001. Scale bar = 40 μm (C).
    Plaque Forming Units, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plaque-forming+units/pm32380150-50-6-9?v=GraphPad+Software+Inc
    Average 90 stars, based on 1 article reviews
    plaque-forming units - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    plaque forming units (pfu) usa-wa1/2020 nr-52281  (BEI Resources)
    90
    BEI Resources plaque forming units (pfu) usa-wa1/2020 nr-52281
    Wnt3a reduces ocular hypertension in dexamethasone (Dex)–treated mice. A: GTM3 cells were transfected with the glucocorticoid receptor (GR) signaling reporter vector and transduced with the <t>Ad5-CMV-GFP</t> or Ad5-CMV-Wnt3a+mCherry before luciferase assays. Data were analyzed using one-way analysis of variance and Sidak post-hoc tests. B: Three-month–old female C57BL/6J mice received binocular periocular Dex-acetate (Dex-Ac) injection once a week throughout the study (arrow on the left) after baseline intraocular pressure (IOP) establishment. After ocular hypertension development, Ad5-CMV-GFP was injected intravitreally into one eye and Ad5-CMV-Wnt3a+mCherry was injected into the fellow eye (arrow on the right). Mouse IOP was measured under isoflurane anesthesia about once a week throughout the study in a masked manner. Paired t-test was used to compare IOP at each time point. C: Hematoxylin and eosin (H&E) staining of a mouse eye section transduced with Ad5-Wnt3a-mCherry. D: Immunostaining of a section adjacent to C using the anti-mCherry antibody (red; pseudocolor). Data are given as means ± SD of GR signaling activity (A) or means ± SEM of IOP (B). N = 8 (A); N = 17 (B). ∗P < 0.05; ∗∗P < 0.01, and ∗∗∗∗P < 0.0001. Scale bar = 40 μm (C).
    Plaque Forming Units (Pfu) Usa Wa1/2020 Nr 52281, supplied by BEI Resources, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plaque-forming+units/pmc08055913-281-11-24?v=BEI+Resources
    Average 90 stars, based on 1 article reviews
    plaque forming units (pfu) usa-wa1/2020 nr-52281 - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    plaque-forming units (pfu/ml)  (Cedarlane)
    90
    Cedarlane plaque-forming units (pfu/ml)
    Wnt3a reduces ocular hypertension in dexamethasone (Dex)–treated mice. A: GTM3 cells were transfected with the glucocorticoid receptor (GR) signaling reporter vector and transduced with the <t>Ad5-CMV-GFP</t> or Ad5-CMV-Wnt3a+mCherry before luciferase assays. Data were analyzed using one-way analysis of variance and Sidak post-hoc tests. B: Three-month–old female C57BL/6J mice received binocular periocular Dex-acetate (Dex-Ac) injection once a week throughout the study (arrow on the left) after baseline intraocular pressure (IOP) establishment. After ocular hypertension development, Ad5-CMV-GFP was injected intravitreally into one eye and Ad5-CMV-Wnt3a+mCherry was injected into the fellow eye (arrow on the right). Mouse IOP was measured under isoflurane anesthesia about once a week throughout the study in a masked manner. Paired t-test was used to compare IOP at each time point. C: Hematoxylin and eosin (H&E) staining of a mouse eye section transduced with Ad5-Wnt3a-mCherry. D: Immunostaining of a section adjacent to C using the anti-mCherry antibody (red; pseudocolor). Data are given as means ± SD of GR signaling activity (A) or means ± SEM of IOP (B). N = 8 (A); N = 17 (B). ∗P < 0.05; ∗∗P < 0.01, and ∗∗∗∗P < 0.0001. Scale bar = 40 μm (C).
    Plaque Forming Units (Pfu/Ml), supplied by Cedarlane, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/plaque-forming+units/pmc08189108-83-5-17?v=Cedarlane
    Average 90 stars, based on 1 article reviews
    plaque-forming units (pfu/ml) - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Wnt3a reduces ocular hypertension in dexamethasone (Dex)–treated mice. A: GTM3 cells were transfected with the glucocorticoid receptor (GR) signaling reporter vector and transduced with the Ad5-CMV-GFP or Ad5-CMV-Wnt3a+mCherry before luciferase assays. Data were analyzed using one-way analysis of variance and Sidak post-hoc tests. B: Three-month–old female C57BL/6J mice received binocular periocular Dex-acetate (Dex-Ac) injection once a week throughout the study (arrow on the left) after baseline intraocular pressure (IOP) establishment. After ocular hypertension development, Ad5-CMV-GFP was injected intravitreally into one eye and Ad5-CMV-Wnt3a+mCherry was injected into the fellow eye (arrow on the right). Mouse IOP was measured under isoflurane anesthesia about once a week throughout the study in a masked manner. Paired t-test was used to compare IOP at each time point. C: Hematoxylin and eosin (H&E) staining of a mouse eye section transduced with Ad5-Wnt3a-mCherry. D: Immunostaining of a section adjacent to C using the anti-mCherry antibody (red; pseudocolor). Data are given as means ± SD of GR signaling activity (A) or means ± SEM of IOP (B). N = 8 (A); N = 17 (B). ∗P < 0.05; ∗∗P < 0.01, and ∗∗∗∗P < 0.0001. Scale bar = 40 μm (C).

    Journal: The American Journal of Pathology

    Article Title: The Canonical Wnt Signaling Pathway Inhibits the Glucocorticoid Receptor Signaling Pathway in the Trabecular Meshwork

    doi: 10.1016/j.ajpath.2021.02.018

    Figure Lengend Snippet: Wnt3a reduces ocular hypertension in dexamethasone (Dex)–treated mice. A: GTM3 cells were transfected with the glucocorticoid receptor (GR) signaling reporter vector and transduced with the Ad5-CMV-GFP or Ad5-CMV-Wnt3a+mCherry before luciferase assays. Data were analyzed using one-way analysis of variance and Sidak post-hoc tests. B: Three-month–old female C57BL/6J mice received binocular periocular Dex-acetate (Dex-Ac) injection once a week throughout the study (arrow on the left) after baseline intraocular pressure (IOP) establishment. After ocular hypertension development, Ad5-CMV-GFP was injected intravitreally into one eye and Ad5-CMV-Wnt3a+mCherry was injected into the fellow eye (arrow on the right). Mouse IOP was measured under isoflurane anesthesia about once a week throughout the study in a masked manner. Paired t-test was used to compare IOP at each time point. C: Hematoxylin and eosin (H&E) staining of a mouse eye section transduced with Ad5-Wnt3a-mCherry. D: Immunostaining of a section adjacent to C using the anti-mCherry antibody (red; pseudocolor). Data are given as means ± SD of GR signaling activity (A) or means ± SEM of IOP (B). N = 8 (A); N = 17 (B). ∗P < 0.05; ∗∗P < 0.01, and ∗∗∗∗P < 0.0001. Scale bar = 40 μm (C).

    Article Snippet: After ocular hypertension development (about 2 weeks after initial Dex-acetate injection), 3 × 10 7 plaque-forming units Ad5-CMV-GFP were intravitreally injected into the right eye, and 3 × 10 7 plaque-forming units Ad5-CMV-mouseWnt3a+mCherry (co-expression, not a fusion protein) (Vector Biolabs, Malvern, PA) were intravitreally injected into the left eye under anesthesia.

    Techniques: Transfection, Plasmid Preparation, Transduction, Luciferase, Injection, Staining, Immunostaining, Activity Assay